Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-10-18

FDA Approved: DEXTROAMPHETAMINE SULFATE — Original Application (SUNRISE PHARMACEUTICAL, INC.)

View source ↗

Summary

FDA approved Sunrise Pharmaceutical's generic dextroamphetamine sulfate under an original application (ANDA210059).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextroamphetamine sulfate (dextroamphetamine sulfate)

Snippet

ORIG AP for DEXTROAMPHETAMINE SULFATE (DEXTROAMPHETAMINE SULFATE)